Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: A potential therapy for poor risk B-cell chronic lymphocytic leukaemia

被引:0
|
作者
Elliott, S. L. [1 ]
Crawford, C. W. [1 ]
Summerfield, G. P. [2 ]
Newton, P. [3 ]
Wallis, J. [2 ]
Mainou-Fowler, T. [2 ]
Evans, P. [4 ]
Bedwell, C. [5 ]
Durkacz, B. W. [1 ]
Willmore, E. [1 ]
机构
[1] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Univ Newcastle, Dept Acad Haematol, Newcastle Upon Tyne, Tyne & Wear, England
[3] Sunderland Royal Hosp, Sunderland, England
[4] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
[5] Newcastle Tyne NHS Hosp Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
227
引用
收藏
页码:90 / 90
页数:1
相关论文
共 50 条
  • [1] Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia
    Elliott, Sarah L.
    Crawford, Clark
    Mulligan, Evan
    Summerfield, Geoffrey
    Newton, Paula
    Wallis, Jonathan
    Mainou-Fowler, Tryfonia
    Evans, Paul
    Bedwell, Clare
    Durkacz, Barbara W.
    Willmore, Elaine
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (01) : 61 - 71
  • [2] DNA-Dependent Protein Kinase Is a Therapeutic Target in Poor Prognosis B-Cell Chronic Lymphocytic Leukemia
    Willmore, Elaine
    Elliott, Sarah L.
    Crawford, Clark J.
    Summerfield, Geoffrey
    Mainou-Fowler, Tryfonia
    Jackson, Graham
    Evans, Paul
    Newton, Paula
    Gowans, Duncan
    Durkacz, Barbara W.
    BLOOD, 2008, 112 (11) : 148 - 148
  • [3] DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia
    Willmore, Elaine
    Elliott, Sarah L.
    Mainou-Fowler, Tryfonia
    Summerfield, Geoffrey R.
    Jackson, Graham H.
    O'Neill, Fran
    Lowe, Christopher
    Carter, Anthony
    Harris, Robert
    Pettitt, Andrew R.
    Cano-Soumillac, Celine
    Griffin, Roger J.
    Cowell, Ian G.
    Austin, Caroline A.
    Durkacz, Barbara W.
    CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3984 - 3992
  • [4] ATM Mutant Chronic Lymphocytic Leukaemia Cells are Chemosensitized by Inhibition of DNA-Dependent Protein Kinase
    Willmore, Elaine
    Skowronska, Ana
    Mulligan, Evan A.
    Ahmed, G.
    Elliott, Sarah
    Summerfield, Geoffrey P.
    Hamlen, Karen
    Lowe, Chris
    Durkacz, Barbara W.
    Stankovic, Tanja
    BLOOD, 2010, 116 (21) : 194 - 195
  • [5] Potentiation of chlorambucil cytotoxicity in B-Cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin
    Christodoulopoulos, G
    Muller, C
    Salles, B
    Kazmi, R
    Panasci, L
    CANCER RESEARCH, 1998, 58 (09) : 1789 - 1792
  • [6] Protein kinase C betall is overexpressed in B-cell lymphocytic leukaemia
    Lakum, T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 20 - 20
  • [7] In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia
    Bellosillo, B
    Villamor, N
    Colomer, D
    Pons, G
    Montserrat, E
    Gil, J
    BLOOD, 1999, 94 (08) : 2836 - 2843
  • [8] Polymorphisms of DNA repair and detoxification genes in B-CELL chronic lymphocytic leukaemia
    Ganster, C.
    Neesen, J.
    Jaeger, U.
    Esterbauer, H.
    Mannhalter, C.
    Fonatsch, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 396 - 396
  • [9] The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia
    Morabito, F
    Callea, I
    Console, G
    Stelitano, C
    Sculli, G
    Filangeri, M
    Oliva, B
    Musolino, C
    Iacopino, P
    Brugiatelli, M
    HAEMATOLOGICA, 1997, 82 (05) : 560 - 565
  • [10] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    Blonski, JZ
    Kasznicki, M
    Gora-Tybor, J
    Konopka, L
    Dmoszynska, A
    Skotnicki, AB
    Stella-Holowiecka, B
    Kuliczkowski, K
    Dwilewicz-Trojaczek, J
    BLOOD, 2000, 96 (11) : 293B - 293B